Bharat Biotech
-
Bharat Biotech Announces Phase 3 Results of COVAXIN® : India’s First COVID-19 Vaccine Demonstrates Interim Clinical Efficacy of 81%
India’s First COVID-19 Vaccine Demonstrates Interim Clinical Efficacy of 81% · Data from 25,800 participants, received a vaccine or…
Read More » -
Latest News
PM Congratulates the nation on vaccine approval of Serum Institute of India and Bharat Biotech
The Prime Minister, Narendra Modi has called the DCGI approval of Serum Institute of India and Bharat Biotech vaccines, a…
Read More »
